AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN - US0017441017 - Common Stock
20.78 USD
+0.73 (+3.64%)
20.78 USD
0 (0%)
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 102 industry peers in the Health Care Providers & Services industry. While AMN is still in line with the averages on profitability rating, there are concerns on its financial health. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
In the past 5 years AMN always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -13.46%, AMN is not doing good in the industry: 77.45% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -49.02%, AMN is doing worse than 71.57% of the companies in the same industry.
AMN has a Return On Invested Capital of 2.66%. This is comparable to the rest of the industry: AMN outperforms 47.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is above the industry average of 9.14%.
The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.66%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROIC | 2.66% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin (2.12%) which is comparable to the rest of the industry.
AMN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 29.84%, AMN perfoms like the industry average, outperforming 57.84% of the companies in the same industry.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
AMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
AMN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
AMN has an Altman-Z score of 2.39. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score of 2.39. This is comparable to the rest of the industry: AMN outperforms 55.88% of its industry peers.
The Debt to FCF ratio of AMN is 3.59, which is a good value as it means it would take AMN, 3.59 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.59, AMN is doing good in the industry, outperforming 76.47% of the companies in the same industry.
A Debt/Equity ratio of 1.51 is on the high side and indicates that AMN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.51, AMN is not doing good in the industry: 68.63% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.35
WACC7.55%
2.3 Liquidity
AMN has a Current Ratio of 1.00. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
AMN's Current ratio of 1.00 is on the low side compared to the rest of the industry. AMN is outperformed by 71.57% of its industry peers.
AMN has a Quick Ratio of 1.00. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
AMN has a Quick ratio of 1.00. This is in the lower half of the industry: AMN underperforms 67.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -59.73% in the last year.
Measured over the past 5 years, AMN shows a small growth in Earnings Per Share. The EPS has been growing by 0.80% on average per year.
The Revenue for AMN has decreased by -14.33% in the past year. This is quite bad
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
3.2 Future
Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-64.45%
EPS Next 2Y-41.25%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue Next Year-11.81%
Revenue Next 2Y-6.83%
Revenue Next 3Y-2.9%
Revenue Next 5Y4.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.85, which indicates a very decent valuation of AMN.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 90.20% of the companies listed in the same industry.
AMN is valuated cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
AMN is valuated rather expensively with a Price/Forward Earnings ratio of 18.19.
AMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AMN is cheaper than 64.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.72. AMN is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.85 | ||
| Fwd PE | 18.19 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 83.33% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 98.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.12 | ||
| EV/EBITDA | 7.49 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -22.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)12.24
EPS Next 2Y-41.25%
EPS Next 3Y-22.59%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
20.78
+0.73 (+3.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.62%
Inst Owner Change-1.07%
Ins Owners0.42%
Ins Owner Change1.98%
Market Cap796.29M
Analysts69.23
Price Target20.69 (-0.43%)
Short Float %10.06%
Short Ratio4.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.83%
Min EPS beat(2)53.64%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)56.81%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)34.9%
EPS beat(12)12
Avg EPS beat(12)26.31%
EPS beat(16)16
Avg EPS beat(16)23.47%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.88%
Revenue beat(4)3
Avg Revenue beat(4)1.99%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.84%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)11
Avg Revenue beat(16)1.97%
PT rev (1m)-23.55%
PT rev (3m)-29%
EPS NQ rev (1m)-5.17%
EPS NQ rev (3m)-32.25%
EPS NY rev (1m)3.21%
EPS NY rev (3m)16.5%
Revenue NQ rev (1m)-3.93%
Revenue NQ rev (3m)-5.96%
Revenue NY rev (1m)-1.65%
Revenue NY rev (3m)-2.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.85 | ||
| Fwd PE | 18.19 | ||
| P/S | 0.29 | ||
| P/FCF | 3.12 | ||
| P/OCF | 2.56 | ||
| P/B | 1.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.49 |
EPS(TTM)2.11
EY10.15%
EPS(NY)1.14
Fwd EY5.5%
FCF(TTM)6.67
FCFY32.08%
OCF(TTM)8.11
OCFY39.02%
SpS72.28
BVpS15.86
TBVpS-12.28
PEG (NY)N/A
PEG (5Y)12.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROCE | 3.58% | ||
| ROIC | 2.66% | ||
| ROICexc | 2.73% | ||
| ROICexgc | 8.39% | ||
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% | ||
| FCFM | 9.22% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 33.64% | ||
| Cap/Sales | 1.99% | ||
| Interest Coverage | 1.13 | ||
| Cash Conversion | 139.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.39 |
F-Score4
WACC7.55%
ROIC/WACC0.35
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
EPS Next Y-64.45%
EPS Next 2Y-41.25%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
Revenue Next Year-11.81%
Revenue Next 2Y-6.83%
Revenue Next 3Y-2.9%
Revenue Next 5Y4.4%
EBIT growth 1Y-70.44%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year93.69%
EBIT Next 3Y30.53%
EBIT Next 5YN/A
FCF growth 1Y-32.27%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.9%
OCF growth 3Y1.61%
OCF growth 5Y7.34%